Process / pipelineGerontologyFrailty-phenotypePipeline

FRAIL Frailty Scale

Also known as: FRAIL Scale, FRAIL Index

OriginatorJohn E. MorleyYear2012Sources3Related methods11

The FRAIL Scale is a brief, five-item clinical screening tool developed by John E. Morley and colleagues to identify frailty in older adults. Designed as a simple and efficient alternative to more comprehensive frailty assessments, it incorporates the key domains of the frailty phenotype: fatigue, resistance, ambulation, illness, and weight loss. The FRAIL Scale is widely used in primary care, hospital, and long-term care settings to stratify risk and guide management decisions.

Key highlights

  • Brevity and simplicity: five items requiring <2 minutes of administration time and no special equipment, making it highly feasible for use in busy clinical settings and primary care.
  • Incorporates core frailty domains: captures the essential phenotypic components (fatigue, mobility, resistance, illness, weight loss) without excessive redundancy.
  • Clinical relevance: all five items are clinically meaningful and address domains modifiable by intervention; weight loss and fatigue are actionable targets.
  • Population validity: developed and validated across diverse community-dwelling and hospitalized older adult populations, with reproducible predictive validity.
  • Strong prognostic utility: frailty status predicts hospitalization, disability, institutionalization, and mortality, with high positive predictive value for adverse outcomes.

Intuition

This section is available to Pro members. Upgrade to Pro

How it works

This section is available to Pro members. Upgrade to Pro

When to use it

The FRAIL Scale is used in primary care clinics, hospital wards, emergency departments, and long-term care facilities as a rapid first-line screening tool for frailty. Administer it to older adults aged 65 and above, particularly those presenting with non-specific symptoms (falls, functional decline, cognitive impairment) or multiple comorbidities. Use the FRAIL Scale when (1) quick risk stratification is needed to guide triage or intervention, (2) identifying candidates for comprehensive geriatric assessment or multidisciplinary intervention, (3) screening hospitalized older patients to predict length of stay and discharge planning, (4) monitoring response to frailty interventions, or (5) population-level frailty screening in primary care. It is suitable for brief encounters where detailed assessment is not feasible.

Strengths & limitations

Strengths
  • Brevity and simplicity: five items requiring <2 minutes of administration time and no special equipment, making it highly feasible for use in busy clinical settings and primary care.
  • Incorporates core frailty domains: captures the essential phenotypic components (fatigue, mobility, resistance, illness, weight loss) without excessive redundancy.
  • Clinical relevance: all five items are clinically meaningful and address domains modifiable by intervention; weight loss and fatigue are actionable targets.
  • Population validity: developed and validated across diverse community-dwelling and hospitalized older adult populations, with reproducible predictive validity.
  • Strong prognostic utility: frailty status predicts hospitalization, disability, institutionalization, and mortality, with high positive predictive value for adverse outcomes.
Limitations
  • Limited validation in non-Western populations: most validation data come from North American and European cohorts; applicability to other regions may be limited.
  • Subjective and recall-dependent items: fatigue and weight loss rely on subjective report and 3-month recall, introducing potential for underreporting or overestimation.
  • Modest diagnostic accuracy: sensitivity and specificity are moderate compared to comprehensive frailty assessments; it is best viewed as a screening rather than definitive diagnostic tool.
  • Does not distinguish functional limitation from frailty: a person with functional impairment due to chronic disease may score high without meeting physiological frailty criteria.
  • Missing objective measures: absence of objectively timed performance tests (e.g., gait speed, grip strength) compared to other frailty phenotype measures.

Common pitfalls

This section is available to Pro members. Upgrade to Pro

Applications

This section is available to Pro members. Upgrade to Pro

Frequently asked

What is the difference between pre-frailty (score 1-2) and frailty (score 3-5), and why does it matter clinically?

Pre-frail individuals (score 1-2) show early signs of frailty and are at intermediate risk for future disability and mortality, but have not yet developed the full phenotype. This group is the primary target for preventive interventions (exercise, nutrition optimization, social engagement) that can reverse decline or prevent progression to clinical frailty. Frail individuals (score ≥3) require more intensive, multidisciplinary management including comprehensive assessment of underlying causes and potentially more aggressive medical optimization.

Should objective weight loss be verified by reviewing medical records, or is patient report acceptable?

Patient report of unintentional weight loss is used for screening; however, if weight loss is a key clinical concern or if the patient's report is unreliable, review of recent clinic visit weights or asking about changes in clothing fit can provide corroboration. Documentation in the medical record is ideal but not required for FRAIL scoring; the tool is designed for rapid clinical assessment using available history.

How does a FRAIL score relate to biological frailty markers such as grip strength or gait speed?

The FRAIL Scale captures the clinical phenotype of frailty through self-reported and observable domains, but does not include objective performance measures. It correlates with grip strength, gait speed, and physical activity level but is not a substitute for performance-based assessment. Ideally, FRAIL screening is combined with objective measures such as the Short Physical Performance Battery for comprehensive frailty phenotyping.

Can the FRAIL Scale be used in individuals with cognitive impairment or dementia?

The FRAIL Scale relies on accurate patient history and self-report. In moderate to severe cognitive impairment, responses may be unreliable. In mild cognitive impairment, collateral history from a caregiver can supplement patient report. For individuals with significant dementia, informant-based assessment or objective measures (weight trends, medication review) may be more reliable than direct patient questioning.

Sources

  1. 1.
    Morley, J. E., Vellas, B., van Kan, G. A., et al. (2013). Frailty consensus: a call to action. J Am Med Dir Assoc, 14(6), 392-397.
  2. 2.
    Abellan van Kan, G., Rolland, Y., Bergman, H., et al. (2008). The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging, 12(1), 29-37.
  3. 3.
    Morley, J. E., Haren, M. T., Rolland, Y., & Kim, M. J. (2012). Frailty. Med Clin North Am, 96(2), 395-399.

You have read it. What now?

Cite this page

ScholarGate. (2026, June 3). FRAIL. ScholarGate. https://scholargate.app/gerontology/frail-scale

FRAIL Frailty Scale | ScholarGate